NSE · Healthcare · Medical Care Facilities
| Document | Date |
|---|---|
| Annual report FY2026 GUJARAT KIDNEY & SUPERSPECIALITY LIMITED - ANNUAL REPORT 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from Operations (Consolidated): ₹8,201.34 Lacs ( | 2026-09-03 |
| Quarterly results · Q1 FY27 DOCUMENT SUMMARY: GUJARAT KIDNEY AND SUPERSPECIALITY LIMITED IMPORTANT NOTICE • This document is an auditor's review report only – it does NOT conta | 2026-08-14 |
| Quarterly results | 2026-08-05 |
| Quarterly results | 2026-07-10 |
| Quarterly results · Q4 FY26 Gujarat KIDNEY AND SUPERSPECIALITY LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Revenue from Operations (FY 2026): 4,010.02 lacs (up 14% from 3,51 | 2026-05-28 |
| Quarterly results · Q3 FY26 GUJARAT KIDNEY AND SUPERSPECIALITY LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Revenue from operations (Half Year ended Sept 30, 2025): Rs 2,109. | 2026-03-25 |
| Quarterly results | 2026-03-13 |
Readable in the app.
| Announcement | Date |
|---|---|
| Acquisition of 51% stake in Blue Tree Clinics LLC Gujarat Kidney and Super Speciality Limited announced three key Board decisions on July 9, 2026: 1. **UAE Acquisition**: The company will acquire a 51% majority stake in Blue Tree Clinics L | 2026-07-09 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Gujarat Kidney And Super Speciality Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.